Aurinia Pharmaceuticals Inc (AUPH) valuation · P/E 7.2, $1.03B cap
Aurinia Pharmaceuticals Inc (AUPH) P/E 7.2, $1.03B cap.
| Metric | Value |
|---|---|
| P/E | 7.2 |
| Market cap | $1.03B |
| Revenue | $83.2M |
| P/S | 12.3 |
AUPH valuation FAQ
What is AUPH's P/E ratio?
Aurinia Pharmaceuticals Inc (AUPH) trailing P/E is 7.2 on the latest cached fundamentals snapshot.
What is AUPH's market cap?
Aurinia Pharmaceuticals Inc (AUPH) market cap is $1.03B on the latest cached fundamentals snapshot.
What is AUPH's latest revenue?
Latest cached Aurinia Pharmaceuticals Inc (AUPH) revenue was $83.2M. Statements: https://lician.com/financials/auph
What is AUPH's price-to-sales ratio?
Aurinia Pharmaceuticals Inc (AUPH) price-to-sales (P/S) is 12.3, cached market cap $1.03B divided by revenue $83.2M.
How many AUPH valuation scalars are listed on this page?
This page lists 4 cached valuation scalars for Aurinia Pharmaceuticals Inc (AUPH): P/E, Market cap, Revenue, and P/S.
Where is AUPH valuation listed?
Cached valuation multiples for Aurinia Pharmaceuticals Inc (AUPH) are listed at https://lician.com/valuation/auph.
Not investment advice. Cached rows, not a live tape.